Περίληψη:
Background The purpose of our study is to examine the long (5-year)
efficacy of the all surface laser ablation (ASLA) combined with
accelerated cross-linking (CXL) for the treatment of myopia without the
use of mitomycin-C (MMC). Methods This retrospective study consisted of
202 eyes of 118 myopic (SD: 2.41, range: - 1.50 to - 12.75 D) patients
(44 males, 74 females). Mean age was 28.50 years (SD: 6.45, range: 18 to
51 years) that underwent ASLA with accelerated CXL for the treatment of
their myopia. Results The patients underwent routine postoperative
assessment on the 1st, 3rd, 7th day and in the 1st, 3rd, 6th and 12th
month, 30th month (+/- 6 months), 4th and 5th year. The mean spherical
equivalent (SEq) refractive error changed from - 6.41 +/- 2.41 D
preoperatively to - 0.02 +/- 0.53 D at 5 years postoperatively. The haze
score was 0.18, 0.25 and 0.28 at 1, 3 and 6 months postoperatively. At
12 months after the treatment, no eyes had significant corneal haze and
in all the following postoperative time intervals the haze traces were
gone. Conclusion ASLA combined with accelerated CXL (ASLA-XTRA) appears
to be safe, efficacious and offering very good refractive results. The
potential additional benefits of this modality are the stabilizing
effect of the refraction and its sterilization effect on the treated
cornea without the potential side effects of MMC.
Συγγραφείς:
Aslanides, Ioannis M.
Hafezi, Farhad
Chen, Shihao
Mukherjee,
Hatch
Selimis, Vasileios
Maragkos, Ilias
Lu, Nanji and
Kymionis, George
